Side-by-side comparison of AI visibility scores, market position, and capabilities
2024: Revenue $200M (up from $105.3M); 100,000+ organizations (5,000 customers); customers include Cars.com, GoFundMe, Grab, ClassPass, Uplight, Beyond Finance, Foursquare
JumpCloud is a cloud-based directory platform that provides identity and access management, device management, and zero trust security for distributed organizations with hybrid IT environments. The company serves IT administrators and organizations who need to manage user identities, authenticate access, and secure devices across on-premise, cloud, and remote work environments from a single platform. JumpCloud unifies directory services, single sign-on, multi-factor authentication, and endpoint management to help organizations move beyond traditional Active Directory while maintaining security and control over users, devices, and resources.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.